Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Merck
Healthtrust
Fish and Richardson
Boehringer Ingelheim
Cipla
US Army
AstraZeneca
Harvard Business School
Express Scripts

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071136

« Back to Dashboard

NDA 071136 describes DIAZEPAM, which is a drug marketed by Lannett Holdings Inc, Abraxis Pharm, Hospira, Marsam Pharms Llc, Parenta Pharms, Us Army, Warner Chilcott, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Actavis Elizabeth, Barr, Dava Pharms Inc, Duramed Pharms Barr, Ferndale Labs, Halsey, Ivax Sub Teva Pharms, Martec Usa Llc, Mayne Pharma, Mylan, Pioneer Pharms, Roxane, Teva Pharms, Upsher-smith Labs, Vintage Pharms, and Virtus Pharms, and is included in seventy-one NDAs. It is available from forty-seven suppliers. Additional details are available on the DIAZEPAM profile page.

The generic ingredient in DIAZEPAM is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for 071136
Tradename:DIAZEPAM
Applicant:Mayne Pharma
Ingredient:diazepam
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 071136
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIAZEPAM diazepam TABLET;ORAL 071136 ANDA Actavis Pharma, Inc. 0591-5620 0591-5620-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5620-01)
DIAZEPAM diazepam TABLET;ORAL 071136 ANDA Actavis Pharma, Inc. 0591-5620 0591-5620-05 500 TABLET in 1 BOTTLE, PLASTIC (0591-5620-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Feb 3, 1987TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Julphar
Chubb
McKesson
Dow
Healthtrust
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot